As a part of the Inflation Reduction Act of 2022, CMS is requiring manufacture rebates for certain Medicare Part B drugs in which the cost has exceeded inflation. Beneficiaries out of pocket costs will be reduced to 20% of the inflation-adjusted payment described in the Act.
03/21/23 • 5 min
Generate a badge
Get a badge for your website that links back to this episode
Select type & size
<a href="https://goodpods.com/podcasts/pharmacy-revenue-cycle-podcast-530696/beat-inflation-with-a-part-b-rebate-68755770"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to beat inflation with a part b rebate on goodpods" style="width: 225px" /> </a>
Copy